Espee Formulation Private Limited, a active private limited company, was established on 28 July 1988 in Rajkot, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1988PTC011043. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹9.00 M and a paid-up capital of ₹8.00 M.
It upholds a compliant status. Employing 24 professional, Its leadership includes Vijay Ramniklal Badani (Whole-Time Director), Virendra Champaklal Kothari (Whole-Time Director), Jayesh Kantilal Desai (Director). Past directors included Jayesh Kantilal Desai. It holds ₹2.28 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sector No : 2 Plot No : 15 Shapar, Rajkot, Gujarat, 360002.
U24231GJ1988PTC011043
011043
28 July 1988
₹9.00 M
₹8.00 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Espee Formulation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijay Ramniklal Badani | Whole-Time Director | 28 Jul 1988 | Current |
| Virendra Champaklal Kothari | Whole-Time Director | 28 Jul 1988 | Current |
| Jayesh Kantilal Desai | Director | 21 Dec 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Espee Formulation Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.25% decrease. The company also saw a substantial improvement in profitability, with a 43.26% increase in profit. The company's net worth observed a substantial decline by a decrease of 34.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Espee Formulation had a promoter holding of 33.08% and a public holding of 66.92%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹22,782,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Nov 2021 | Others | ₹2.00 M | Open |
| 08 Jun 2020 | Others | ₹4.00 M | Open |
| 27 Dec 2019 | Others | ₹4.44 M | Open |
| 02 Jan 1998 | Others | ₹4.88 M | Open |
| 12 Dec 1997 | Central Bank Of India | ₹1.50 M | Open |
Explore comprehensive loan charge details -
Espee Formulation has a workforce of 24 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Espee Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Espee Formulation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Espee Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Espee Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 2.00 M with Charge ID 100514120 was registered on 29 Nov 2021. was completed.
A charge with Others amounted to Rs. 4.00 M with Charge ID 100345215 was registered on 08 Jun 2020. was recorded as a recent event.
A charge with Others amounted to Rs. 4.44 M with Charge ID 100317427 was registered on 27 Dec 2019. was recorded as a recent event.
The activity A charge with Others of Rs. 4.88 M registered on 02 Jan 1998 with Charge ID 90100578 was modified on 15 Feb 2018. was completed.
The CIN of Espee Formulation Private Limited is U24231GJ1988PTC011043.
Espee Formulation Private Limited is headquartered at Sector No : 2 Plot No : 15 Shapar, Rajkot, Gujarat, 360002.
Espee Formulation Private Limited was incorporated on 28 July 1988.
The current directors of Espee Formulation Private Limited are
The primary industry of Espee Formulation Private Limited is Manufacturing.
Espee Formulation Private Limited is unlisted.
The authorized capital of Espee Formulation Private Limited is ₹9.00 M, and the paid-up capital is ₹8.00 M.
The compliance status of Espee Formulation Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX